allergan inc deal is set for esprit pharma with eye on bladder treatment allergan inc which is testing its blockbuster antiwrinkle drug botox as a treatment for overactive bladders agreed to buy esprit pharma inc for &# million to expand its role in treating bladder disorders closely held esprit sells an overactive bladder drug called sanctura and u s regulators recently approved a once daily version of the pill called sanctura xr that allergan said could eventually bring in annual sales of as much as &# million botox which works by paralyzing nerves is one of the few other types of treatments now being researched for overactive bladders a condition that affects an estimated million americans 
